Table 2.
Implant-related infections with 90-day versus 1-year post-operative surveillance protocol
Pre-IPB | Post-IPB | Pre-IPB | Post-IPB | |||||
---|---|---|---|---|---|---|---|---|
Surgical Cases | Infectio ns (%) | Infectio ns (%) | Infectio ns (%) | Infectio ns (%) | ||||
All Case Types | ||||||||
90-day surveillance | 332 | 11 (3.3%) | 356 | 1 (0.3%) | 546 | 16 (2.9%) | 615 | 1 (0.2%) |
1-year surveillance | 15 (4.5%) | 3 (0.8%) | 17 (3.1%) | 4 (0.7%) | ||||
All DBS Cases | ||||||||
90-day surveillance | 188 | 2 (1.1%) | 198 | 0 (0%) | 298 | 3 (1.0%) | 343 | 0 (0%) |
1-year surveillance | 3 (1.6%) | 1 (0.5%) | 4 (1.3%) | 1 (0.3%) | ||||
Electro de Cases | ||||||||
90-day surveillance | 76 | 2 (2.6%) | 72 | 0 (0%) | 106 | 2 (1.9%) | 116 | 0 (0%) |
1-year surveillance | 2 (2.6%) | 0 (0%) | 2 (1.9%) | 0 (0%) | ||||
DBS IPG Cases | ||||||||
90-day surveillance | 112 | 1 (0.9%) | 126 | 0 (0%) | 192 | 1 (0.5%) | 227 | 0 (0%) |
1-year surveillanc | 2 (1.8%) | 1 (0.8%) | 2 (1.0%) | 1 (0.4%) | ||||
All SCS Cases | ||||||||
90-day surveillance | 51 | 0 (0%) | 58 | 0 (0%) | 98 | 0 (0%) | 105 | 0 (0%) |
1-year surveillance | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) | ||||
All IT Pump Cases | ||||||||
90-day surveillance | 93 | 8 (8.6%) | 100 | 1 (1.0%) | 150 | 13 (8.7%) | 167 | 1 (0.6%) |
1-year surveillance | 8 (8.6%) | 2 (2.0%) | 13 (8.7%) | 3 (1.8%) |
IPB = Infection prevention bundle
DBS = deep brain stimulation
IPG = implantable pulse generator
SCS = spinal cord stimulator
IT = intrathecal
All case types = SCS+DBS+IT pumps